Benzinga's Top Downgrades (BMRN, ARO, APWR, BUCY)

UBS downgraded BioMarin Pharmaceutical Inc BMRN from "buy" to "neutral." BMRN's shares closed at $27.15 yesterday. BioMarin Pharmaceutical's earnings are likely to fall by 101.65% this year. Raymond James downgraded Aeropostale Inc ARO from "outperform" to "market perform." ARO's stocks closed at $26.80 yesterday. Aeropostale's 52-week trading range is $19.10-$32.24. A-Power Energy Generation Systems Ltd APWR was downgraded by Oppenheimer from “outperform” to “perform.” APWR's shares closed at $4.74 yesterday. APWR's earnings may decline by 30.32% in the next year. Bucyrus International Inc BUCY was downgraded by Goldman from “buy” to “neutral.” BUCY's shares closed at $89.10 yesterday. Bucyrus' quarterly earnings dropped 21.95% y/y. More Analyst Ratings here